MHAT Pazardzhik AD

Pazardzhik 4401

0 studies enrolling now · 9 studies all time

What they study most

Acute Myocardial Infarction (AMI), Cardiovascular Disease, Cardiovascular Risk, Chronic Kidney Failure, Colitis, Ulcerative, Diabetes Mellitus, Type 2, Dyslipidemia, Ischemic Stroke; Ischemic Attack, Transient, Severe Hypertriglyceridemia, Type2 Diabetes, Ulcerative Colitis

Studies at this site

• ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels — Running, not enrolling
• A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before — Completed
• A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia — Completed
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis — Completed
• Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC — Stopped early
• Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride — Stopped early